Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Dexmedetomidine for PONV in Laparoscopic Hysterectomy
NCT03809923Completed
- Sponsor
- Anqing Municipal Hospital
- Start
- Jun 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and dexmedetomidine in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Anqing Municipal Hospital. Primary endpoints: Incidence of Postoperative Nausea and Vomiting (0-2 hours), Incidence of Postoperative Nausea and Vomiting (2-24 hours) and 1 more. Started Jun 2019; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03809923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809923.